Last updated at 31 Aug 2024 09:54 AM
Director
DIN: 08257511
Munish Manchanda is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08257511.Munish Manchanda is currently involved in 2 different roles. Their most recent position is with PROSEM HEALTHCARE PRIVATE LIMITED as a Director. The first company Munish Manchanda was appointed to as a director was BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED. Munish Manchanda is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Munish Manchanda is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08257511.Munish Manchanda is currently involved in 2 different roles. Their most recent position is with PROSEM HEALTHCARE PRIVATE LIMITED as a Director. The first company Munish Manchanda was appointed to as a director was BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED. Munish Manchanda is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED | Director | 15-Oct-2018 |
| BIOFRANK PHARMACEUTICALS (INDIA) PRIVATE LIMITED | Individual Promoter | 15-Oct-2018 |
| PROSEM HEALTHCARE PRIVATE LIMITED | Director | 06-Oct-2023 |